Search

Your search keyword '"Pruim, J."' showing total 29 results

Search Constraints

Start Over You searched for: Author "Pruim, J." Remove constraint Author: "Pruim, J." Topic radiopharmaceuticals Remove constraint Topic: radiopharmaceuticals
29 results on '"Pruim, J."'

Search Results

1. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

2. Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer.

3. Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer.

4. Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies.

5. Alternative PET tracers in head and neck cancer. A review.

6. Oesophageal tumour progression between the diagnostic ¹⁸F-FDG-PET and the ¹⁸F-FDG-PET for radiotherapy treatment planning.

7. Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.

8. Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer.

9. 18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement.

10. Visualization of small glottic laryngeal cancer using methyl-labeled 11C-methionine positron emission tomography.

11. Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.

12. FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases.

13. Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.

14. Fluordeoxyglucose positron emission tomography contributes to management of pediatric liver transplantation candidates with fever of unknown origin.

15. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer.

16. Therapy evaluation of laryngeal carcinomas by tyrosine-pet.

17. L-1-11C-tyrosine PET in patients with laryngeal carcinomas: comparison of standardized uptake value and protein synthesis rate.

18. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

19. Better yield of (18)fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation.

20. Visualisation and assessment of the protein synthesis rate of lung cancer using carbon-11 tyrosine and positron emission tomography.

21. Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.

22. Carbon-11 choline or FDG-PET for staging of oesophageal cancer?

23. Radiolabeled amino acids: basic aspects and clinical applications in oncology.

24. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

25. L-[1-11C]-tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer.

26. Detection of unknown occult primary tumors using positron emission tomography.

27. 11C-tyrosine position emission tomography and 1H magnetic resonance spectroscopy of the response of brain gliomas to radiotherapy

28. Visualization of Prostate Cancer with <F>11C-Choline</F> Positron Emission Tomography

29. Visualization of small glottic laryngeal cancer using methyl-labeled 11C-methionine positron emission tomography

Catalog

Books, media, physical & digital resources